Public company info - CStone Pharmaceuticals , 02616.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

CStone Pharmaceuticals, 02616.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12
Net Cash Flow from Operating Activities -612,469 -1,484,024 -508,070 -1,080,722 -791,107 -240,186 -213,006
Net Cash Flow from Return on Investments & Servicing of Finance -2,136 7,450 21,543 38,915 5,111 5,754 44
　Interest Received 9,672 9,692 22,863 39,218 5,111 6,054 44
　Interest Paid -11,808 -2,242 -1,320 -303 0 -300 0
　Dividend Received 0 0 0 0 0 0 0
　Dividend Paid 0 0 0 0 0 0 0
　Others 0 0 0 0 0 0 0
Taxes (Paid) / Refunded 0 0 0 0 0 0 0
Net Cash Flow from Investing Activities 355,447 -836,244 1,157,869 -698,102 -382,812 262,246 -753,513
　Additions to Fixed Assets 0 -85,900 -31,628 -6,213 -7,012 -12,130 -1,101
　Disposal of Fixed Assets 0 0 0 0 0 0 0
　Increase in Investments 0 -190,297 0 -34,065 -286,360 -3,743,048 -767,879
　Decrease in Investments 69,391 10,125 8,482 121,795 664,666 4,017,661 15,390
　Net Cash Flow with Related Parties 0 0 0 0 -307,219 0 304,029
　Others 286,056 -570,172 1,181,015 -779,619 -446,887 -237 -303,952
Net Cash Flow before Financing Activities -259,158 -2,312,818 671,342 -1,739,909 -1,168,808 27,814 -966,475
Net Cash Flow from Financing Activities 40,275 94,546 1,390,749 2,091,635 1,662,420 0 1,010,503
　New Loans 113,042 96,215 58,582 0 0 0 0
　Loans Repayment -75,296 -18,499 -6,961 -4,683 0 0 0
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Equity Financing 2,529 16,830 1,360,928 2,096,318 1,969,639 0 706,474
　Net Cash Flow with Related Parties 0 0 0 0 -307,219 0 304,029
　Others 0 0 -21,800 0 0 0 0
Increase(Decrease) in Cash & Cash Equivalents -218,883 -2,218,272 2,062,091 351,726 493,612 27,814 44,028
Cash & Cash Equivalents at Beginning of Year 742,724 3,024,548 1,126,436 701,336 83,390 59,539 15,511
Net Cash Flow due to Change in Exchange Rate/Others 34,843 -63,552 -163,979 73,374 124,334 -3,963 0
Cash & Cash Equivalents at End of Year 558,684 742,724 3,024,548 1,126,436 701,336 83,390 59,539
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 
88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved